By 2030, the population in the United States aged 65 and older is expected to reach 71 million or about 20% of Americans.

A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family ...

As the use of obesity medications, such as GLP-1 receptor agonists, continues to expand, the American College of Lifestyle Medicine (ACLM) has released a new Obesity Medications & Lifestyle Medicine ...

Add Yahoo as a preferred source to see more of our stories on Google. For years, medical experts have defined obesity primarily based on body mass index, which measures stored fat by calculating ...

Illustration of human lymphocytes. (Ruslanas Baranauskas/Science Photo Library) Defeating obesity is rarely easy. For many ...

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity ...

By Mariam Sunny and Christy Santhosh May 5 (Reuters) - Pfizer said on Tuesday that it expects to return to stronger growth ...

Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...

The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an alternative to obesity drugs given by injection.

Increasing screen time, reduced physical activity and ultra-processed foods in everyday diet is driving childhood obesity in ...

Obesity can increase your chance of kidney stones. Experts don’t know exactly why this is, but losing weight may help lower your chance of developing them. Obesity is a chronic health condition ...